• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,991.22 790.54
( 1.04%)
Global Indices
Nasdaq
51,704.04 -29.67
(-0.06%)
Dow Jones
7,389.07 -104.72
(-1.40%)
Hang Seng
69,343.30 -445.08
(-0.64%)
Nikkei 225
10,453.87 25.02
(0.24%)
Forex
USD-INR
94.53 0.21
(0.22%)
EUR-INR
108.18 0.03
(0.03%)
GBP-INR
125.09 0.39
(0.31%)
JPY-INR
0.58 0.00
(0.06%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
489.430006
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
41.42
1375.64
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0.03
 

fredun pharmaceuticals ltd
Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter
May 29,2026
Net profit of Fredun Pharmaceuticals rose 79.67% to Rs 10.78 crore in the quarter ended March 2026 as against Rs 6.00 crore during the previous quarter ended March 2025. Sales rose 27.18% to Rs 210.41 crore in the quarter ended March 2026 as against Rs 165.44 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.25% to Rs 32.62 crore in the year ended March 2026 as against Rs 19.74 crore during the previous year ended March 2025. Sales rose 40.21% to Rs 633.33 crore in the year ended March 2026 as against Rs 451.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales210.41165.44 27 633.33451.71 40
OPM %13.7310.43 -13.9212.16 -
PBDT14.409.10 58 55.2432.53 70
PBT11.257.26 55 47.0027.49 71
NP10.786.00 80 32.6219.74 65